Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial

Published:2021-01 Issue:10269 Volume:397 Page:119-127
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Juan-Giner Aitana,Kimathi Derick,Grantz Kyra H,Hamaluba Mainga,Kazooba Patrick,Njuguna Patricia,Fall Gamou,Dia Moussa,Bob Ndeye S,Monath Thomas P,Barrett Alan D,Hombach Joachim,Mulogo Edgar M,Ampeire Immaculate,Karanja Henry K,Nyehangane Dan,Mwanga-Amumpaire Juliet,Cummings Derek A T,Bejon Philip,Warimwe George M,Grais Rebecca F

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Vaccines and vaccination against yellow fever;Wkly Epidemiol Rec,2013

2. Yellow fever vaccine supply: a possible solution;Monath;Lancet,2016

3. WHO position on the use of fractional doses—June 2017, addendum to vaccines and vaccination against yellow fever. WHO: position paper—June 2013;Vaccine,2017

4. Yellow fever in Africa and the Americas, 2018;Wkly Epidemiol Rec,2019

5. Studies on yellow fever vaccine III-dose response in volunteers;Lopes de Souza;J Biol Stand,1988

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study – A complementary study;Vaccine;2024-10

2. Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda, 2019–2020 — Preliminary report;Vaccine;2024-09

3. Febre Amarela no Brasil: reflexões sobre segurança e efetividade da vacina;Caderno Pedagógico;2024-07-29

4. Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines;The Lancet Infectious Diseases;2024-06

5. Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study;The Lancet Infectious Diseases;2024-06